Immuno Nano Med: Funding, Investors & Team (Sep 2026)
Immuno Nano Med is a company developing next-generation vaccines for infectious diseases.
Immuno Nano Med has raised $20k across 1 funding round on record, the most recent an undisclosed round of $20k announced in Nov 2025.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Immuno Nano Med Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Immuno Nano Med Funding Rounds
Immuno Nano Med Founders and Leadership Team
Contact details for the Immuno Nano Med team: 1 of 1 has an email address on file.
Start 14-day free trial →Immuno Nano Med Funding Compared to Other Health Care Startups
Immuno Nano Med's latest round of $20k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immuno Nano Med in Health Care and Ames
Companies Similar to Immuno Nano Med
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Immuno Nano Med Funding FAQs
What does Immuno Nano Med do?
Immuno Nano Med is a company developing next-generation vaccines for infectious diseases.
How much funding has Immuno Nano Med raised?
Immuno Nano Med has raised $20k across 1 round on record. The most recent is an undisclosed round of $20k announced in Nov 2025.
When did Immuno Nano Med last raise funding?
Immuno Nano Med's most recent funding round on record is an undisclosed round of $20k, announced in Nov 2025.
Who founded Immuno Nano Med?
FundedIQ lists Kevin Legge (Founder) at Immuno Nano Med.
Where is Immuno Nano Med headquartered?
Immuno Nano Med is based in Ames, Iowa, United States.
How many employees does Immuno Nano Med have?
Immuno Nano Med is in the 1-10 employee band.
How does Immuno Nano Med's funding compare to other Health Care startups?
Immuno Nano Med's latest round of $20k is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Immuno Nano Med Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immuno Nano Med is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.